Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Janssen terminates Avicidin agreement with NeoRx

Oct. 2, 1998

Onyx expands ONYX-015 clinical trials in pancreatic cancer

Oct. 2, 1998

Progesterone antagonists claimed for cancer, gynecological disorders by Meiji Seika

Oct. 1, 1998

Guilford, RPR amend Gliadel marketing and distribution agreement

Oct. 1, 1998

IB-367: preclinical results presented at ICAAC support clinical trials in oral mucositis

Sep. 30, 1998

Celgene initiates development of Thalomid for hematological cancers

Sep. 30, 1998

Pharmacyclics starts phase III Gd-Tex trial for brain metastases

Sep. 28, 1998

Polish researchers present new antitumor agents

Sep. 28, 1998

Investigators at C&C Research design new antiestrogenic agents

Sep. 28, 1998

HMR grants Matrix rights to anticancer agent about to enter phase II

Sep. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.